Zhengming Yan

Zhujiang Hospital — China

Biochemistry, Genetics and Molecular Biology · Life Sciences

14h-index809citations56works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Microtubule and mitosis dynamics(10), Cancer-related Molecular Pathways(9), Medical Imaging Techniques and Applications(8), Cancer, Hypoxia, and Metabolism(8), Computational Drug Discovery Methods(7)

Publications56 total

HDAC inhibitors support long-term expansion of porcine hepatocytes in vitro
Biomedicine & Pharmacotherapy·2024Open Access
CCR Translation for This Article from [<sup>18</sup>F]FLT–PET Imaging Does Not Always “Light Up” Proliferating Tumor Cells
2023Open Access
Data from PF-03732010: A Fully Human Monoclonal Antibody against P-Cadherin with Antitumor and Antimetastatic Activity
2023Open Access
Supplementary Figures 1 - 5 from PF-03732010: A Fully Human Monoclonal Antibody against P-Cadherin with Antitumor and Antimetastatic Activity
2023Open Access
Supplementary Figures 1 - 5 from Biomarker and Pharmacologic Evaluation of the γ-Secretase Inhibitor PF-03084014 in Breast Cancer Models
2023Open Access
Supplementary Table 3 from Biomarker and Pharmacologic Evaluation of the γ-Secretase Inhibitor PF-03084014 in Breast Cancer Models
2023Open Access
Data from Biomarker and Pharmacologic Evaluation of the γ-Secretase Inhibitor PF-03084014 in Breast Cancer Models
2023Open Access
Supplementary Table 2 from Biomarker and Pharmacologic Evaluation of the γ-Secretase Inhibitor PF-03084014 in Breast Cancer Models
2023Open Access
Supplementary Data from PF-00477736 Mediates Checkpoint Kinase 1 Signaling Pathway and Potentiates Docetaxel-Induced Efficacy in Xenografts
2023Open Access
Supplementary Figures 1-3 from [<sup>18</sup>F]FLT–PET Imaging Does Not Always “Light Up” Proliferating Tumor Cells
2023Open Access
Data from PF-00477736 Mediates Checkpoint Kinase 1 Signaling Pathway and Potentiates Docetaxel-Induced Efficacy in Xenografts
2023Open Access
Supplementary Table 1 from Biomarker and Pharmacologic Evaluation of the γ-Secretase Inhibitor PF-03084014 in Breast Cancer Models
2023Open Access
Supplementary Data from PF-00477736 Mediates Checkpoint Kinase 1 Signaling Pathway and Potentiates Docetaxel-Induced Efficacy in Xenografts
2023Open Access
Data from Biomarker and Pharmacologic Evaluation of the γ-Secretase Inhibitor PF-03084014 in Breast Cancer Models
2023Open Access
Supplementary Figures 1 - 5 from PF-03732010: A Fully Human Monoclonal Antibody against P-Cadherin with Antitumor and Antimetastatic Activity
2023Open Access
Data from [<sup>18</sup>F]FLT–PET Imaging Does Not Always “Light Up” Proliferating Tumor Cells
2023Open Access
Supplementary Table 3 from Biomarker and Pharmacologic Evaluation of the γ-Secretase Inhibitor PF-03084014 in Breast Cancer Models
2023Open Access
CCR Translation for This Article from [<sup>18</sup>F]FLT–PET Imaging Does Not Always “Light Up” Proliferating Tumor Cells
2023Open Access
Supplementary Figures 1-3 from [<sup>18</sup>F]FLT–PET Imaging Does Not Always “Light Up” Proliferating Tumor Cells
2023Open Access
Data from PF-03732010: A Fully Human Monoclonal Antibody against P-Cadherin with Antitumor and Antimetastatic Activity
2023Open Access
page 1 of 3Next →

Frequent Co-authors

Cory L. Painter(31), James G. Christensen(28), Anthony Wong(27), Cathy C. Zhang(24), Kyle Kuszpit(19), Patrick B. Lappin(19), Maruja E. Lira(18), Kenneth Zasadny(18), Cathy Zhang(16), Maria E. Arango(15), Dana Buckman(14), Mary E. Spilker(13), Qing Zong(12), Tod Smeal(12), Qin Zhang(9), Gerrit Los(9), Adam Pavlı́c̀ek(9), Nathan V. Lee(9), Paul A. Rejto(9), Tim Nichols(8)